The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression

Human Pathology

Volumn 42, Issue 1, 2011, Pages 25-35

  Xing, Ya Nan ^a   Yang, Xue ^a   Xu, Xiao Yan ^a   Zheng, Yang ^b   Xu, Hui Mian ^a   Takano, Yasuo ^b   Zheng, Hua Chuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Gastric carcinoma; ING5; Pathogenesis; Prognosis; Progression

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; MESSENGER RNA; PROTEIN ING5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; CORRELATION ANALYSIS; DYSPLASIA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ADOLESCENT; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROGNOSIS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 78650014980     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.024     Document Type: Article

References (32)

1. Kodama M., Kodama T., and Murakami M. Oncogene activation and tumor suppressor gene inactivation find their sites of expression in the changes in time and space of the age-adjusted cancer incidence rate In Vivo 14 2000 725 734
2. Gunduz M., Demircan K., Gunduz E., Katase N., Tamamura R., and Nagatsuka H. Inhibitor of Growth(ING) family: a emerging molecular target for cancer therapy J Hard Tissue Biol 17 2008 1 10
3. Soliman M.A., and Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins Trends Biochem Sci 32 2007 509 519
4. Wang Y., Wang J., and Li G. Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis FEBS Lett 580 2006 3787 3793
5. Unoki M., Kumamoto K., Takenoshita S., and Harris C.C. Reviewing the current classification of inhibitor of growth family proteins Cancer Sci 100 2009 1173 1179
6. Champagne K.S., Saksouk N., and Peña P.V. The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide Proteins 72 2008 1371 1376
7. Ullah M., Pelletier N., and Xiao L. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes Mol Cell Biol 28 2008 6828 6843
8. Doyon Y., Cayrou C., and Ullah M. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation Mol Cell 21 2006 51 64
9. Shiseki M., Nagashima M., and Pedeux R.M. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity Cancer Res 63 2003 2373 2378
10. Oki E., Maehara Y., Tokunaga E., Kakeji Y., and Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer Cancer Lett 147 1999 157 162
11. Ding H.Z., Yang D., and Wu F.R. p33 (ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues Zhonghua Yi Xue Za Zhi 83 2003 320 323
12. Garkavtsev I., Kozin S.V., and Chernova O. The candidate tumour suppressor protein ING4 regulates brain tumor growth and angiogenesis Nature 428 2004 328 332
13. Kim S., Chin K., Gray J.W., and Bishop J.M. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer Proc Natl Acad Sci U S A 101 2004 16251 16256
14. Wang Y., Dai D.L., Martinka M., and Li G. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma Clin Cancer Res 13 2007 4111 4116
15. Zhang J.T., Wang D.W., and Li Q.X. Nuclear to cytoplasmic shift of p33 (ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables J Cancer Res Clin Oncol 134 2008 421 426
16. Li M., Jin Y., and Sun W.J. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma J Pathol 219 2009 87 95
17. Shah S., Smith H., Feng X., Rancourt D.E., and Riabowol K. ING function in apoptosis in diverse model systems Biochem Cell Biol 87 2009 117 125
18. Cengiz B., Gunduz M., and Nagatsuka H. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer Oral Oncol 43 2007 241 247
19. X. Li, T. Nishida, and A. Noguchi Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma J Cancer Res Clin Oncol 136 2010 1573 1583
20. Cengiz B, Gunduz E, Gunduz M, et al. Tumor-specific mutation and down-regulation of ING5 detected in oral squamous cell carcinoma. Int J Cancer [in press].
21. Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathological behaviors of carcinomas. Hum Pathol [in press].
22. Kelley J.R., and Duggan J.M. Gastric cancer epidemiology and risk factors J Clin Epidemiol 56 2003 1 9
23. Zheng H.C., Xu X.Y., and Xing Y.N. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas Hum Pathol 41 2010 724 736
24. Misdraji J., and Lauwers G.Y. Gastric epithelial dysplasia Semin Diagn Pathol 19 2002 20 30
25. Gologan A., Graham D.Y., and Sepulveda A.R. Molecular markers in Helicobacter pylori- associated gastric carcinogenesis Clin Lab Med 25 2005 197 222
26. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumours 6th ed. 2002 John Wiley & Sons Hoboken (NJ)
27. Zheng H.C., Takahashi H., and Murai Y. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray J Clin Pathol 60 2007 273 277
28. Kumada T., Tsuneyama K., Hatta H., Ishizawa S., and Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 2004 1141 1149
29. Kumamoto K., Fujita K., and Kurotani R. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression Int J Cancer 125 2009 1306 1315
30. Zhang H.K., Pan K., and Wang H. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma Cancer Lett 261 2008 183 192
31. Zheng H.C., Takahashi H., and Li X.H. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas Virchows Arch 452 2008 147 155
32. Zheng H.C., Takahashi H., and Nakajima T. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays J Cancer Res Clin Oncol 132 2006 817 823